Patent · US Expired

Dopamine D4 ligands for the treatment of novelty-seeking disorders

US6548502B2 · kind B2 · utility

7Cited by
10References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 26, 2001
Grant dateApr 15, 2003
Priority date
Expiry dateJul 26, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a method of treating or preventing a novelty-seeking disorder, such as pathological gambling, attention deficit disorder with hyperactivity disorder and sex addiction, comprising administering a compound which is a dopamine D4 receptor ligand, or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.